BOOTHBAY FUND MANAGEMENT, LLC

Position in DBVT — DBV Technologies S.A.

CIK 1549230 NEW YORK, NY

Position in DBVT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,679,776

-$733,670 QoQ

Shares Held

163,401

0.0% QoQ

Ownership

0.260%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#21

of 78 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. DBVT ranks #56 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	465,787	$87,232,589
2	ABVX	Abivax S.A.	563,367	$75,074,286
3	EXEL	Exelixis, Inc.	804,095	$43,750,808
4	PCVX	Vaxcyte, Inc.	534,163	$31,050,895
5	COGT	Cogent Biosciences, Inc.	692,825	$26,812,327
6	CGEM	Cullinan Therapeutics, Inc.	1,082,611	$19,714,346
7	TNGX	Tango Therapeutics, Inc.	500,497	$15,645,536
8	AVTX	Avalo Therapeutics, Inc.	702,051	$12,973,902

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,679,776	163,401	0.0%	Shares	Other	2026-08-14
2026-03-31	$3,413,446	163,401	0.0%	Shares	Other	2026-05-15
2025-12-31	$3,132,397	163,401	+397.2%	Shares	Other	2026-02-17
2022-06-30	$83,795	32,861	0.0%	Shares	Other	2022-08-15
2022-03-31	$52,248	32,861	0.0%	Shares	Other	2022-05-16
2021-12-31	$52,577	32,861	0.0%	Shares	Other	2022-02-14
2021-09-30	$161,018	32,861	-27.7%	Shares	Other	2021-11-15
2021-06-30	$248,326	45,481	0.0%	Shares	Other	2021-08-17
2021-03-31	$242,413	45,481	-9.9%	Shares	Other	2021-05-17
2020-12-31	$132,304	50,498	+73.5%	Shares	Other	2021-02-12
2020-09-30	$50,339	29,098	0.0%	Shares	Other	2020-11-16
2020-06-30	$127,740	29,098	—	Shares	Other	2020-08-14
No filing history on record for this holder in this stock.